Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy.

Metabolism: clinical and experimental - 1 Jan 2013

Manson Joann E

Abstract excerpt

Menopausal estrogen therapy has a complex balance of benefits and risks and is no longer routinely recommended for the majority of women during or after the transition to menopause. Recent findings from the Women's Health Initiative (WHI) and other studies suggest that a woman's clinical and biological characteristics may modify her health outcomes on hormone therapy (HT) and that some women may be more...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, LDL
Share to Coronary Disease
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Administration Schedule

Share to Estrogen Replacement Therapy

Share to Evidence-Based Medicine

Share to Menopause

Share to Patient Selection

Source

Identifiers

PMID: 23018143
DOI: 10.1016/j.metabol.2012.08.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy.PMID 23018143Read ↗

Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.Semantic proximity Read ↗

Improving Cardiovascular Clinical Competencies for the Menopausal TransitionSemantic proximity Read ↗

Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: a framework for personalized risk assessment and counseling.Semantic proximity Read ↗

Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatmentSemantic proximity Read ↗

DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy.Semantic proximity Read ↗

Associations of endogenous and exogenous hormonal exposures and cardiovascular disease in women – A FinnGen studySemantic proximity Read ↗

How to comprehensively evaluate & manage cardiovascular risk in breast cancer survivors?Semantic proximity Read ↗

Predictors of cardiovascular risk in women.Semantic proximity Read ↗

Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.Semantic proximity Read ↗

Women in healthy transition deep phenotyping cohort study protocol (KiSO-DP): a within-participant multidisciplinary longitudinal cohort study across the menopausal transition.Semantic proximity Read ↗

Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.Semantic proximity Read ↗

Invited review: Pharmacogenetics of estrogen replacement therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.